IP Library Granted Patent US 7,645,596
Granted Patent B2
US 7,645,596 · App. 10/709,436 · Granted Jan 12, 2010

Method of determining the nucleotide sequence of oligonucleotides and DNA molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,645,596
App. No.
10/709,436
Granted
Jan 12, 2010
Kind
B2
Abstract

The present invention relates to a novel method for analyzing nucleic acid sequences based on real-time detection of DNA poly-merase-catalyzed incorporation of each of the four nucleotide bases, supplied individually and serially in a microfluidic system, to a reaction cell containing a template system comprising a DNA fragment of unknown sequence and an oligonucleotide primer. Incorporation of a nucleotide base into the template system can be detected by any of a variety of methods including but not limited to fluorescence and chemiluminescence detection. Alternatively, microcalorimetic detection of the heat generated by the incorporation of a nucleotide into the extending template system using thermopile, thermistor and refractive index measurements can be used to detect extension reactions.

Claims (12)

1. A method for sequencing nucleic acid, the method comprising the steps of:

hybridizing nucleic acid to a complementary nucleic acid sequence to form one or more duplexes;

adding at least one nucleotide comprising a detectable label to said duplex, wherein said nucleotide is not a dideoxy nucleotide and wherein said nucleotide has a free 3′ hydroxyl when added to said duplex;

identifying said nucleotide comprising said detectable label; and

repeating said adding and identifying steps, thereby to determine the sequence of said nucleic acid.

2. The method of claim 1 , wherein said identifying step comprises detecting pyrophosphate production.

3. The method of claim 1 , further comprising amplifying nucleic acid prior to said hybridizing step.

4. The method of claim 1 , further comprising immobilizing said one or more duplexes on a substrate.

5. The method of claim 4 , wherein said one or more duplexes are immobilized such that said one or more duplexes are individually optically resolvable on said substrate.

6. The method of claim 1 , wherein said detectable label is an optically-detectable label.

7. The method of claim 6 , wherein said optically-detectable label is a fluorescent label.

8. The method of claim 6 , wherein said optically-detectable label is a chemiluminescent label.

Assignments (4)
TERMINATION AND RELEASE OF NOTICE OF ATTORNEY'S LIEN Recorded Aug 30, 2018
From: BROWN RUDNICK LLP
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 046988/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031159/0626 →
NOTICE OF ATTORNEY'S LIEN Recorded Apr 17, 2012
From: HELICOS BIOSCIENCES CORPORATION
To: BROWN RUDNICK LLP
Reel/Frame 028060/0898 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2004
From: WILLIAMS, PETER; TAYLOR, THOMAS J.; WILLIAMS, DANIEL J.B.; GOULD, IAN; HAYES, MARK A.
To: ARIZONA BOARD OF REGENTS
Reel/Frame 014570/0915 →